- Home
- DERM vs PFD Comparison
DERM vs PFD Comparison
Compare DERM & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- PFD
- Stock Information
- Founded
- DERM 2014
- PFD 1990
- Country
- DERM United States
- PFD United States
- Employees
- DERM N/A
- PFD N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- PFD Investment Managers
- Sector
- DERM Health Care
- PFD Finance
- Exchange
- DERM Nasdaq
- PFD Nasdaq
- Market Cap
- DERM 174.7M
- PFD 144.5M
- IPO Year
- DERM 2021
- PFD N/A
- Fundamental
- Price
- DERM $6.88
- PFD $11.08
- Analyst Decision
- DERM Strong Buy
- PFD
- Analyst Count
- DERM 2
- PFD 0
- Target Price
- DERM $10.00
- PFD N/A
- AVG Volume (30 Days)
- DERM 78.2K
- PFD 33.2K
- Earning Date
- DERM 05-20-2025
- PFD 01-01-0001
- Dividend Yield
- DERM N/A
- PFD 6.30%
- EPS Growth
- DERM N/A
- PFD N/A
- EPS
- DERM N/A
- PFD N/A
- Revenue
- DERM $56,134,000.00
- PFD N/A
- Revenue This Year
- DERM $29.83
- PFD N/A
- Revenue Next Year
- DERM $54.88
- PFD N/A
- P/E Ratio
- DERM N/A
- PFD N/A
- Revenue Growth
- DERM N/A
- PFD N/A
- 52 Week Low
- DERM $3.20
- PFD $8.53
- 52 Week High
- DERM $7.84
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- DERM 52.73
- PFD 58.60
- Support Level
- DERM $6.47
- PFD $10.95
- Resistance Level
- DERM $7.15
- PFD $11.10
- Average True Range (ATR)
- DERM 0.49
- PFD 0.10
- MACD
- DERM -0.09
- PFD 0.04
- Stochastic Oscillator
- DERM 37.25
- PFD 88.54
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.